Retatrutide Peptide Overview

Retatrutide (LY3437943) is a novel synthetic peptide composed of 39 amino acids. It is a triple hormone receptor agonist that targets three distinct receptors: the Glucagon-Like Peptide-1 (GLP-1) receptor, the Glucose-Dependent Insulinotropic Polypeptide (GIP) receptor, and the Glucagon receptor (GCGR). This “triple G” mechanism is designed to maximize metabolic benefits, potentially offering superior efficacy in weight management and glycemic control compared to single or dual agonists.   

Mechanism of Action

Retatrutide exhibits synergistic activity across three metabolic pathways:   

• GIP Receptor: Activation helps regulate blood sugar by stimulating insulin secretion and may improve lipid metabolism.   
• GLP-1 Receptor: improved insulin sensitivity, delayed gastric emptying (slowing digestion), and reduced appetite signaling in the brain.   
• Glucagon Receptor: Activation increases energy expenditure (burning calories) and promotes lipid catabolism (fat breakdown) in the liver, which is distinct from other incretin-based therapies.   

Research and Clinical Studies

• Weight Loss: Clinical trials (Phase 2) have reported substantial weight reductions, with some participants achieving up to 24.2% mean weight loss after 48 weeks of administration.   
• Liver Health: Research indicates potent effects on reducing liver fat content, with studies showing significant clearance of liver fat in subjects with metabolic dysfunction-associated steatotic liver disease (MASLD).   
• Glycemic Control: Studies demonstrate significant reductions in HbA1c levels in subjects with Type 2 diabetes.   
• Cardiometabolic Profile: Research suggests improvements in blood pressure and lipid profiles (cholesterol and triglycerides) associated with the peptide’s use.   

Chemical Makeup

• Molecular Formula: C221H342N46O68   
• Molecular Weight: ~4731.33 g/mol   
• CAS Number: 2381089-83-2   
• Structure: A 39-amino acid peptide backbone modified at the 20th position with a C20 fatty diacid moiety to extend its half-life (allowing for once-weekly dosing potential).   

Note: This product is sold by Republic One Labs for research and laboratory purposes only and is not intended for human consumption.